| 日期 | 內部人 | 職稱 | 代碼 | 股數 | 價格 | 金額 |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | Tregoning Kathleen | See Remarks | A | 175,000 | $0.0000 | $0.00 |
| Jun 9, 2026 | Renaud Ronald C JR | CEO & President | M | 38,094 | $0.0000 | $0.00 |
| Jun 9, 2026 | Renaud Ronald C JR | CEO & President | M | 38,094 | $5.2500 | $199.99K |
| Apr 20, 2026 | Kaplan Andrew T. | Director, 10% Owner | C | 17,857,143 | $0.0000 | $0.00 |
| Apr 20, 2026 | Kaplan Andrew T. | Director, 10% Owner | P | 8,398,438 | $16.0000 | $134.38M |
| Apr 20, 2026 | Bain Capital Life Sciences Investors, LLC | 10% Owner | C | 4,145,768 | $0.0000 | $0.00 |
| Apr 20, 2026 | Bain Capital Life Sciences Investors, LLC | 10% Owner | C | 16,875,000 | $0.0000 | $0.00 |
| Apr 20, 2026 | Bain Capital Life Sciences Investors, LLC | 10% Owner | P | 1,562,500 | $16.0000 | $25.00M |
| Apr 20, 2026 | Kaplan Andrew T. | Director, 10% Owner | C | 17,857,143 | – | – |
| Apr 20, 2026 | Bain Capital Life Sciences Investors, LLC | 10% Owner | C | 4,145,768 | – | – |
| Apr 20, 2026 | Bain Capital Life Sciences Investors, LLC | 10% Owner | C | 16,875,000 | – | – |
| Apr 20, 2026 | Koppel Adam | Director, 10% Owner | C | 4,145,768 | $0.0000 | $0.00 |
| Apr 20, 2026 | Koppel Adam | Director, 10% Owner | C | 16,875,000 | $0.0000 | $0.00 |
| Apr 20, 2026 | Koppel Adam | Director, 10% Owner | P | 1,562,500 | $16.0000 | $25.00M |
| Apr 20, 2026 | Koppel Adam | Director, 10% Owner | C | 4,145,768 | – | – |
| Apr 20, 2026 | Koppel Adam | Director, 10% Owner | C | 16,875,000 | – | – |
| Apr 20, 2026 | BAIN CAPITAL INVESTORS LLC | 10% Owner | C | 17,857,143 | $0.0000 | $0.00 |
| Apr 20, 2026 | BAIN CAPITAL INVESTORS LLC | 10% Owner | P | 8,398,438 | $16.0000 | $134.38M |
| Apr 20, 2026 | BAIN CAPITAL INVESTORS LLC | 10% Owner | C | 17,857,143 | – | – |
| Apr 20, 2026 | RTW INVESTMENTS, LP | 10% Owner | C | 2,026,820 | – | – |
| Apr 20, 2026 | RTW INVESTMENTS, LP | 10% Owner | C | 8,250,000 | – | – |
| Apr 20, 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10% Owner | C | 2,034,133 | $0.0000 | $0.00 |
| Apr 20, 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10% Owner | C | 9,477,719 | $0.0000 | $0.00 |
| Apr 20, 2026 | RTW INVESTMENTS, LP | 10% Owner | P | 500,000 | $16.0000 | $8.00M |
| Apr 20, 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10% Owner | C | 2,034,133 | – | – |
| Apr 20, 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10% Owner | C | 9,477,719 | – | – |
| Apr 20, 2026 | RTW INVESTMENTS, LP | 10% Owner | C | 10,276,820 | – | – |
| Apr 16, 2026 | Kaplan Andrew T. | Director, 10% Owner | A | 38,300 | $0.0000 | $0.00 |
| Apr 16, 2026 | Koppel Adam | Director, 10% Owner | A | 38,300 | $0.0000 | $0.00 |
| Apr 16, 2026 | Hite Christopher | Director | A | 38,300 | $0.0000 | $0.00 |
| Apr 16, 2026 | Pagan Douglas W. | Chief Financial Officer | A | 100,000 | $0.0000 | $0.00 |
| Apr 16, 2026 | Pagan Douglas W. | Chief Financial Officer | A | 100,000 | $0.0000 | $0.00 |
| Apr 16, 2026 | Clyburn Frank | Director | A | 38,300 | $0.0000 | $0.00 |
| Apr 16, 2026 | MACKAY MARTIN | Director | A | 38,300 | $0.0000 | $0.00 |
| Apr 16, 2026 | Wasserman Scott M. | Chief Medical Officer | A | 100,000 | $0.0000 | $0.00 |
| Apr 16, 2026 | Wasserman Scott M. | Chief Medical Officer | A | 100,000 | $0.0000 | $0.00 |
| Apr 16, 2026 | MILLIGAN JOHN F | Director | A | 38,300 | $0.0000 | $0.00 |
| Apr 16, 2026 | Coleman Jamie Beth | Chief Commercial Officer | A | 75,000 | $0.0000 | $0.00 |
| Apr 16, 2026 | Coleman Jamie Beth | Chief Commercial Officer | A | 75,000 | $0.0000 | $0.00 |
| Apr 16, 2026 | Burgess Paul D. | See Remarks | A | 100,000 | $0.0000 | $0.00 |
| Apr 16, 2026 | Burgess Paul D. | See Remarks | A | 100,000 | $0.0000 | $0.00 |
| Apr 16, 2026 | Renaud Ronald C JR | CEO & President | A | 300,000 | $0.0000 | $0.00 |
| Apr 16, 2026 | Renaud Ronald C JR | CEO & President | A | 300,000 | $0.0000 | $0.00 |
| Apr 16, 2026 | Akamine Scott | Chief Legal Officer | A | 60,000 | $0.0000 | $0.00 |
| Apr 16, 2026 | Akamine Scott | Chief Legal Officer | A | 60,000 | $0.0000 | $0.00 |
| Apr 16, 2026 | Cloghessy Paula | Chief People Officer | A | 60,000 | $0.0000 | $0.00 |
| Apr 16, 2026 | Cloghessy Paula | Chief People Officer | A | 60,000 | $0.0000 | $0.00 |